Zhitong Financial APP News, 002462.SZ released a half-annual report for 2022, achieving operating income of 12.706 billion yuan, an increase of 1.15% over the same period last year. The net profit belonging to shareholders of listed companies was 169 million yuan, down 3.24% from the same period last year. The net profit after deducting non-recurring gains and losses belonging to shareholders of listed companies was 162 million yuan, down 4.83% from the same period last year. Basic earnings per share is 0.58 yuan per share.

The company actively gives full play to the subjective initiative of the team, faces up to difficulties, pays close attention to implementation, and firmly ensures that the company's four main business sectors, namely, pharmaceutical sales, medical devices, pharmaceutical equipment logistics and chain retail, can still effectively cope with the impact and show strong business resilience by actively optimizing inventory scheduling, logistics transfer, personnel deployment and other means under the adverse market environment such as collection policy and COVID-19 epidemic situation. Although in the first quarter, in an unfavorable market environment, operating income reached 6.448 billion yuan, an increase of 11% over the same period last year, with the further severity and complexity of the national epidemic situation in the second quarter, the company's business, especially in Shanghai, was greatly impacted. The company's revenue still lags behind the target.